| 17:09 | European ADRs Move Higher in Thursday Trading |  |
| 14:06 | COVID : oltre 362,8 mln casi e 5,62 mln morti nel mondo |  |
| 12:32 | Mindestens 43 Millionen Menschen haben Booster-Impfung erhalten |  |
| 08:23 | Auch Moderna startet klinische Studie mit Omikron-Impfstoff | |
| 08:01 | Krankenhäuser erwarten viele neue Corona-Patienten | |
| 07:21 | Pfizer tests omicron vaccine in humans | |
| 06:31 | Moderna a commencé les essais d'un rappel de vaccin spécifique contre Omicron |  |
| 05:57 | Moderna startet klinische Studie zu Omikron-Impfstoff | |
| 04:44 | Pfizer-BioNTech, Moderna COVID-19 Jabs Shown Safe For Women Undergoing IVF in Study | |
| 00:19 | Moderna starts trial for Omicron-specific booster shot | |
| 26/01 | Health Care Down On Growth Doubts -- Health Care Roundup | |
| 26/01 | L'Europe finit dans le vert en attendant la Fed | |
| 26/01 | European shares show signs of recovery as Fed meeting awaited | |
| 26/01 | GLOBAL MARKETS LIVE : Vodafone, Qualcomm, Microsoft, Tesla, Intel... | |
| 26/01 | BioNTech to Establish Vaccine Production Facility in Ghana | |
| 26/01 | MARKETSCREENER'S WORLD PRESS REVIEW : January 26, 2022 | |
| 26/01 | BioNTech plant kräftigen Stellenausbau am Standort Marburg | |
| 26/01 | BioNTech Plans 50% Workforce Boost, $57 Million Investment At German Factory | |
| 26/01 | Dreiviertel der Bürger mindestens einmal gegen Corona geimpft | |
| 26/01 | Borse Europa estendono recupero, occhi investitori su meeting Fed | |
| 26/01 | PLANÈTE BOURSE : La revue de presse du mercredi 26 janvier 2022 | |
| 26/01 | ¿Necesita una mano? |  |
| 26/01 | EN DIRECT DES MARCHES : Airbus, EDF, Faurecia, Orpea, Valneva, Seb, Nvidia, Microsoft, Lon.. | |
| 26/01 | Business investment into Singapore dropped 31% in 2021 | |
| 26/01 | Business investment into Singapore dropped 31% in 2021 | |
| 26/01 | Instadeep raises $100m to ramp up real world' ai technology | |
| 26/01 | Hersteller starten klinische Studien zu Omikron-Impfstoff | |
| 25/01 | S&P ends down after another wild session | |
| 25/01 | Pfizer starts clinical study on safety of Omicron-targeted vaccine | |
| 25/01 | MÄRKTE USA/Uneinheitlich - Amex und IBM stützen Dow | |
| 25/01 | Pfizer, BioNTech Launch Clinical Study of Omicron-Specific COVID-19 Vaccine | |
| 25/01 | Pfizer, BioNTech start testing Omicron vaccine | |
| 25/01 | MÄRKTE USA/Börsen nach Vortages-Turbulenzen erneut auf Talfahrt | |
| 25/01 | Fauci dice que es "prudente" tener una vacuna para ómicron, pero que puede no ser neces.. | |
| 25/01 | Résumé des principales informations économiques du mardi 25 janvier | |
| 25/01 | MÄRKTE USA/Börsen starten nach Vortages-Turbulenzen im Minus | |
| 25/01 | Pfizer e BioNTech lanciano studio su vaccino contro variante Omicron | |
| 25/01 | RKI : Rund 316 000 Impfungen am Montag - größtenteils Auffrischungen | |
| 25/01 | Les valeurs à suivre aujourd'hui à Wall Street - Mardi 25 janvier 2022 | |
| 25/01 | BIONTECH : Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine i.. | |
| 25/01 | MÄRKTE USA/Börsen nach Turbulenzen mit Verlusten erwartet | |
| 25/01 | PFIZER : BioNTech débutent l'essai du vaccin Omicron | |
| 25/01 | COVID : prosegue calo ricoveri negli Stati Uniti | |
| 25/01 | BioNTech teme que las exigencias regulatorias retrasen su vacuna para ómicron | |
| 25/01 | Pfizer begins study to test COVID-19 vaccine tweaked to fight Omicron variant | |
| 25/01 | PFIZER : lancement d'une étude pour un vaccin Omicron | |
| 25/01 | BIONTECH : watchdogs' requirements may defer planned launch of Omicron shot | |
| 25/01 | BioNTech, Google, Deutsche Bahn back African-founded AI firm | |
| 25/01 | Pfizer y BioNTech inician ensayo de vacuna contra el COVID enfocada en ómicron | |
| 25/01 | Pfizer and BioNTech launch trial of Omicron-targeted COVID vaccine | |
| 25/01 | JOHNSON & JOHNSON : 3 à 3,5 miliards de dollars de vaccins anti-Covid en 2022 | |
| 25/01 | Pfizer, BioNTech to Study Omicron-Based COVID-19 Vaccine in Adults | |
| 25/01 | Pfizer, BioNTech Start Clinical Study On Omicron-based Vaccine | |
| 25/01 | Biontech und Pfizer beginnen klinische Studie zu Omikron-Impfstoff | |
| 25/01 | Pfizer-BioNTech débutent l'essai clinique d'un vaccin contre Omicron | |
| 25/01 | Pfizer und BioNTech beginnen klinische Studie zu Omikron-basiertem COVID-19-Impfstoff b.. | |
| 25/01 | Pfizer und BioNTech beginnen klinische Studie zu Omikron-basiertem COVID-19-Impfstoff b.. | |
| 25/01 | Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults.. | |
| 25/01 | INTELLIGENCE ARTIFICIELLE : Instadeep lève 100 millions de dollars | |
| 25/01 | Germany to receive 3.8 mln doses of Novavax's new COVID vaccine in Q1 | |
| 25/01 | Elicera Therapeutics AB (publ) Interim Report 1 January - 31 December 2021 | |
| 24/01 | BIONTECH : Pfizer and BioNTech Publish Data from Two Laboratory Studies on COVID-19 Vaccin.. | |
| 24/01 | Chile to purchase 2 million Moderna COVID-19 vaccine doses | |
| 24/01 | SCHOLZ : Neue Kampagne soll Impfquote steigern | |
| 24/01 | VACUNADOS CON SINOVAC RECIBEN FUERTE : estudio | |
| 24/01 | PFIZER : trois doses valent mieux que deux contre Omicron | |
| 24/01 | RKI : 73,4 vollständig gegen Corona geimpft - 75,5 Prozent erstgeimpft | |
| 24/01 | TODAY ON WALL STREET : It's going to be an eventful week | |
| 24/01 | BÖRSE STUTTGART-NEWS : Euwax Trends | |
| 24/01 | Pfizer-BioNTech Booster Shot Effective Against Omicron, New Study Finds | |
| 24/01 | BIONTECH : Pfizer and BioNTech Publish Data from Two Laboratory Studies on COVID-19 Vaccin.. | |
| 24/01 | USA-Les valeurs à suivre à Wall Street (actualisé) | |
| 24/01 | Israeli Study Finds Fourth Vaccine Dose Increases Resistance To COVID-19 In People Over.. | |
| 24/01 | Who chief tedros says biontech will announce start of production… | |
| 24/01 | Corona-Kurs halten - Wieder Corona-Beratungen von Bund und Ländern | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
